Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 14Active not recruiting 7Terminated 6Unknown 4Completed 4Not yet recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Estrogen Receptor Positive Breast Cancer 1

Interventions

Cisplatin 9Specimen Handling 7Educational Status 7Standard of Care 6Interviews as Topic 6Drug Therapy 6Carboplatin 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Observation 4Lenalidomide 4Fluorouracil 4Fluorodeoxyglucose F18 4Dexamethasone 4pembrolizumab 3lenvatinib 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Gemcitabine 3Exercise 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Transurethral Resection of Bladder × Clear all
NCT06629233 2025-08-29

Tn-Miner

University Ghent

Phase NA Enrolling by invitation
36 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡